[Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
作者信息
Gadducci A, Facchini V, Bartolini T, Fioretti P
出版信息
Ann Ostet Ginecol Med Perinat. 1988 May-Jun;109(3):151-5.
PMID:3207319
Abstract
摘要
相似文献
1
[Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
Ann Ostet Ginecol Med Perinat. 1988 May-Jun;109(3):151-5.
2
Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.癌胚抗原、组织多肽抗原和鳞状细胞癌抗原在宫颈癌检测中的评估。
Zhonghua Yi Xue Za Zhi (Taipei). 1992 Jul;50(1):7-13.
3
Ca-125 levels in the conditioned media of the gynecological tumor cell lines.妇科肿瘤细胞系条件培养基中的Ca-125水平。
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Jan;37(1):147-8.
4
[Tumor markers in uterine cancers].[子宫癌中的肿瘤标志物]
Gan To Kagaku Ryoho. 2002 Feb;29(2):333-40.
5
[Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Dec;37(12):2872-5.
6
Immuno-histological localization of tissue polypeptide antigen (TPA) in gynecological malignancies.
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Oct;37(10):2117-20.
7
8
Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.肿瘤标志物癌胚抗原（CEA）、组织多肽抗原（TPA）和鳞状细胞癌抗原（SCC-Ag）在国际妇产科联盟（FIGO）低风险IB期和IIA期子宫颈鳞状细胞癌患者中的应用。
Gynecol Oncol. 2000 Jan;76(1):103-6. doi: 10.1006/gyno.1999.5665.
9
[Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
Nihon Gan Chiryo Gakkai Shi. 1984 Aug 20;19(7):1496-504.
10
[Tumor-associated markers in malignant lung neoplasms].
Minerva Med. 1986 Jan 14;77(1-2):19-25.
Zotero 插件